Release Date: 07/02/18 08:23 Summary: Presentation 2017 Year-End Operating and Financial Results Price Sensitive: No Download Document 1.73MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%